 |
PDBsum entry 4urz
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
4urz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Small molecule binding sites on the ras:sos complex can be exploited for inhibition of ras activation.
|
 |
|
Authors
|
 |
J.J.Winter,
M.Anderson,
K.Blades,
C.Brassington,
A.L.Breeze,
C.Chresta,
K.Embrey,
G.Fairley,
P.Faulder,
M.R.Finlay,
J.G.Kettle,
T.Nowak,
R.Overman,
S.J.Patel,
P.Perkins,
L.Spadola,
J.Tart,
J.A.Tucker,
G.Wrigley.
|
 |
|
Ref.
|
 |
J Med Chem, 2015,
58,
2265-2274.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Constitutively active mutant KRas displays a reduced rate of GTP hydrolysis via
both intrinsic and GTPase-activating protein-catalyzed mechanisms, resulting in
the perpetual activation of Ras pathways. We describe a fragment screening
campaign using X-ray crystallography that led to the discovery of three fragment
binding sites on the Ras:SOS complex. The identification of tool compounds
binding at each of these sites allowed exploration of two new approaches to Ras
pathway inhibition by stabilizing or covalently modifying the Ras:SOS complex to
prevent the reloading of Ras with GTP. Initially, we identified ligands that
bound reversibly to the Ras:SOS complex in two distinct sites, but these
compounds were not sufficiently potent inhibitors to validate our stabilization
hypothesis. We conclude by demonstrating that covalent modification of Cys118 on
Ras leads to a novel mechanism of inhibition of the SOS-mediated interaction
between Ras and Raf and is effective at inhibiting the exchange of labeled GDP
in both mutant (G12C and G12V) and wild type Ras.
|
 |
|
|
|
|
 |